SCHEMBL6203735

SCHEMBL6203735

Cc1ccc(S(=O)(=O)CC(=O)c2ccc(C#N)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.66
▸ HSD11B1 P28845 1/20 0.66
▸ LMNA P02545 1/20 0.63
▸ ALDH1A1 P00352 6/20 0.62
▸ PKM P14618 2/20 0.62
▸ MAPT P10636 1/20 0.57
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ KMT2A Q03164 3/20 0.49
▸ BCHE P06276 1/20 0.49
▸ ACHE P22303 1/20 0.49
▸ PAX8 Q06710 1/20 0.49
▸ GSK3B P49841 1/20 0.49
▸ CYP2A6 P11509 1/20 0.47
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29012562 0.87 HSD11B1 (0.83) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL6319697 0.85 GSK3B (0.53) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL29012568 0.80 KMT2A (0.73) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL6199060 0.80 KMT2A (0.73) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL6223332 0.80 KMT2A (0.73) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL2422002 0.80 RECQL (1.00) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL6202982 0.80 HSD11B1 (1.00) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL29609963 0.78 RECQL (0.97) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL30209482 0.78 HSD11B1 (0.82) RECQLHSD11B1LMNAALDH1A1PKM
SCHEMBL28910979 0.78 HSD11B1 (0.68) RECQLHSD11B1LMNAALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272036-A1 Ketones ASTRAZENECA AB (SE) 2005-12-08 — — US claimed
EP-1549600-A1 KETONES AstraZeneca AB (SE) 2005-07-06 — — EP claimed
WO-2004011410-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2004-02-05 — — WO claimed
CN-111978216-B Preparation method of beta-carbonyl sulfone compound 西南医科大学 2023-02-03 — — CN disclosed
US-11040028-B2 Penicinotam derivative, preparation method and use thereof OCEAN UNIVERSITY OF CHINA (CN) 2021-06-22 — — US disclosed
CN-111978216-A Preparation method of beta-carbonyl sulfone compound 西南医科大学 2020-11-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040028-B2 Penicinotam derivative, preparation method and use thereof TPMT, MAPT, TLR4 RECQL 3745/4885HSD11B1 237/4885LMNA 2825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback